An all-in-one adjuvanted therapeutic cancer vaccine targeting dendritic cell cytosol induces long-lived tumor suppression through NLRC4 inflammasome activation
- Resource Type
- Article
- Source
- In
Biomaterials July 2022 286 - Subject
- Language
- ISSN
- 0142-9612